IHM
Iguana Healthcare Management Portfolio holdings
AUM
$133M
This Quarter Return
-5.04%
1 Year Return
+45.66%
3 Year Return
+127.07%
5 Year Return
–
10 Year Return
–
AUM
$156M
AUM Growth
+$156M
(-68%)
Cap. Flow
-$298M
Cap. Flow
% of AUM
-191.36%
Top 10 Holdings %
Top 10 Hldgs %
47.93%
Holding
85
New
15
Increased
–
Reduced
38
Closed
26
Top Buys
| 1 |
Abbott
ABT
|
$4.42M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
$2.9M |
| 3 |
AGN
Allergan plc
AGN
|
$2.63M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$1.84M |
| 5 |
AAAP
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
|
$1.61M |
Top Sells
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$25.5M |
| 2 |
Pfizer
PFE
|
$16.9M |
| 3 |
Ultragenyx Pharmaceutical
RARE
|
$16.9M |
| 4 |
SHPG
Shire pic
SHPG
|
$12.6M |
| 5 |
Zimmer Biomet
ZBH
|
$12.4M |
Sector Composition
| 1 | Healthcare | 81.19% |
| 2 | Energy | 0.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ultragenyx Pharmaceutical
RARE
$2.89B
| $11.3M | 6.72% | 160,000 -240,000 | -60% | -$16.9M |
|
2
Biogen
BIIB
$19.4B
| $9.93M | 5.93% | 35,000 -30,000 | -46% | -$8.51M |
|
|
MDCO
3
DELISTED
Medicines Co
MDCO
| $9.33M | 5.58% | 275,000 -125,000 | -31% | -$4.24M |
|
|
CELG
4
DELISTED
Celgene Corp
CELG
| $9.26M | 5.53% | 80,000 -70,000 | -47% | -$8.1M |
|
5
Amgen
AMGN
$155B
| $7.31M | 4.37% | 50,000 -60,000 | -55% | -$8.77M |
|
|
ALXN
6
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $6.73M | 4.02% | 55,000 -95,000 | -63% | -$11.6M |
|
7
Merck
MRK
$210B
| $6.48M | 3.87% | 110,000 -40,000 | -27% | -$2.35M |
|
|
8
Zimmer Biomet
ZBH
$21B
| $5.16M | 3.08% | 50,000 -120,000 | -71% | -$12.4M |
|
|
NUVA
9
DELISTED
NuVasive, Inc.
NUVA
| $4.72M | 2.82% | 70,000 -130,000 | -65% | -$8.76M |
|
|
DERM
10
DELISTED
Dermira, Inc.
DERM
| $4.55M | 2.72% | 150,000 -150,000 | -50% | -$4.55M |
|
|
11
Abbott
ABT
$231B
| $4.42M | 2.64% | +115,000 | New | +$4.42M |
|
|
AERI
12
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $4.35M | 2.6% | 115,000 -215,000 | -65% | -$8.14M |
|
|
OMED
13
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $4.24M | 2.53% | 550,000 -900,000 | -62% | -$6.94M |
|
14
Glaukos
GKOS
$5.5B
| $4.12M | 2.46% | 120,000 -120,000 | -50% | -$4.12M |
|
|
MZOR
15
DELISTED
Mazor Robotics Ltd.
MZOR
| $3.84M | 2.29% | 175,000 -225,000 | -56% | -$4.93M |
|
|
CLVS
16
DELISTED
Clovis Oncology, Inc.
CLVS
| $3.33M | 1.99% | 75,000 -575,000 | -88% | -$25.5M |
|
17
Merus
MRUS
$4.98B
| $3.17M | 1.89% | 150,000 -250,000 | -63% | -$5.28M |
|
|
KTWO
18
DELISTED
K2M Group Holdings, Inc
KTWO
| $3.01M | 1.8% | 150,000 -180,000 | -55% | -$3.61M |
|
|
ALDR
19
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $2.91M | 1.74% | 140,000 -10,000 | -7% | -$208K |
|
|
WBA
20
DELISTED
Walgreens Boots Alliance
WBA
| $2.9M | 1.73% | +35,000 | New | +$2.9M |
|
21
Elevance Health
ELV
$71.8B
| $2.88M | 1.72% | 20,000 -30,000 | -60% | -$4.31M |
|
|
SPNC
22
DELISTED
Spectranetics Corp
SPNC
| $2.7M | 1.61% | 110,000 -110,000 | -50% | -$2.7M |
|
|
AGN
23
DELISTED
Allergan plc
AGN
| $2.63M | 1.57% | +12,500 | New | +$2.63M |
|
|
GBT
24
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.53M | 1.51% | 175,000 -475,000 | -73% | -$6.86M |
|
25
Supernus Pharmaceuticals
SUPN
$2.53B
| $2.53M | 1.51% | 100,000 -200,000 | -67% | -$5.05M |
|